A&G Pharmaceutical

A&G Pharmaceutical, Inc is a private target discovery biotech company in Columbia, Maryland. A&G focuses on developing targeted therapies with companion diagnostics for cancers with unmet needs based on biological drivers it has identified. A&G has a phase 1 clinical trial for a first-in-human, first-inclass antibody therapy for a target overexpressed in advanced solid malignancies and a prospective study for a circulating biomarker to monitor response to therapy and progression of disease in cancer patients. A&G’s has also pre-clinical assets for ADC to cell surface oncology targets. The company is funded by VC investment, strategic partnership and grants from the National Cancer Institute.